Desensitizing therapies are emerging for food allergies, and being considered for approval by the FDA. But some in the medical… Read more »
The manufacturer of the Viaskin Peanut patch has resubmitted its biologics license application (or BLA) to the FDA – in… Read more »
In its final report analyzing the costs and benefits of two novel peanut allergy desensitization products, the Institute for Clinical… Read more »
What do you get when you undertake a cost-benefit analysis of new therapies when prices have yet to be established… Read more »
They’re the courageous food allergy parents and children testing therapies still in the experimental stages.
In trials, Viaskin Peanut allowed some participants to tolerate 10 times more peanut protein than at the outset.